Prashant Kumar, MD
Pain Medicine · Worcester, MANPI 1073756441
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,423 of the $6,138 with a category attached, or 88.4%. 24 manufacturers reported payments, led by Boston Scientific at 55.6% of the total. Reporting peaked in 2021 at $1,417 and has fallen 94.5% since, to $77 in 2025.
Across 236 payments — averaging $26.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Painteq LLC$660
- SPR Therapeutics, Inc$636
- Medtronic$291
- Saluda Medical Americas, Inc.$150
- Abbott$123
- plus $865 from 18 others
What the payments were for
- Travel & lodging$68711%
- Food & beverage$5,42388%
- Education$280%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 163 | $3,414 |
| Painteq LLC | 14 | $660 |
| SPR Therapeutics, Inc | 10 | $636 |
| Medtronic(2 entities) | 8 | $291 |
| Saluda Medical Americas, Inc. | 2 | $150 |
| Abbott | 6 | $123 |
| Nevro Corp. | 2 | $121 |
| Collegium Pharmaceutical, Inc. | 6 | $116 |
| Almatica Pharma LLC | 3 | $87 |
| Vertos Medical, Inc. | 3 | $84 |
| Stryker | 2 | $77 |
| Stimwave Technologies Incorporated | 2 | $50 |
| Shionogi Inc | 2 | $45 |
| Valinor Pharma, LLC | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Amgen | 1 | $30 |
| Gilead | 1 | $28 |
| Lilly USA, LLC | 1 | $25 |
| Curonix LLC | 1 | $23 |
| Globus Medical | 1 | $23 |
| Assertio Therapeutics, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $20 |
| Pfizer | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$526
- GENERAL PAIN MANAGEMENT$482
- SPECTRA WAVEWRITER$326
- PAINTEQ$245
- WaveWriter Alpha Prime 16$142
- Evoke$128
How this compares
$6,138 in reported general payments places this provider in the 75th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 49 | $69,788 |
| Xtampza ErOxycodone Myristate | 61 | $53,612 |
| Nucynta ErTapentadol Hcl | 36 | $44,275 |
| BelbucaBuprenorphine Hcl | 35 | $27,330 |
| OxycontinOxycodone Hcl | 33 | $14,880 |
| Gabapentin | 238 | $3,006 |
| Buprenorphine | 13 | $2,801 |
| Tramadol Hcl ErTramadol Hcl | 49 | $2,216 |
| Pregabalin | 157 | $1,813 |
| Lidocaine | 45 | $1,681 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 103 | $1,522 |
| Baclofen | 93 | $1,388 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 98 | $1,197 |
| Morphine Sulfate ErMorphine Sulfate | 60 | $1,085 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 23 | $1,077 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er, Nucynta Er, Belbuca | $116 | $195,005181 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 137 pain medicine providers in Massachusetts.
Other pain medicine in Worcester
- James CelestinWorcester$11K
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Ali EbrahimiBurlington$41K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.